DCC-2036 100mg
DCC-2036 is an orally bioavailable small-molecule inhibitor of multiple tyrosine kinases with potential antineoplastic activity.
| Trivial name | DCC-2036 100mg |
| Catalog Number | A11200-100 |
| Alternative Name(s) | N-[3-tert-Butyl-1-(quinolin-6-yl)-1H-pyrazol-5-yl]-N'-[2-fluoro-4-[(2-(methylcarbamoyl)pyridin-4-yl)oxy]phenyl]urea |
| Molecular Formula | C30H28FN7O3 |
| CAS# | 1020172-07-9 |
| SMILES | CC(C)(C)C1=NN(C(=C1)NC(=O)NC2=C(C=C(C=C2)OC3=CC(=NC=C3)C(=O)NC)F)C4=CC5=C(C=C4)N=CC=C5 |
| Size | 100mg |
| Supplier Page | http://www.adooq.com/dcc-2036.html |